Healthcare providers should consider RSV in patients with respiratory illness, particularly during the RSV season.
Respiratory syncytial virus (RSV) was discovered in 1956 and has since been recognized as one of the most common causes of childhood illness. It causes annual outbreaks of respiratory illnesses in all age groups. In most regions of the United States, RSV circulation starts in the fall and peaks in the winter, but the timing and severity of RSV season in a given community can vary from year to year. Scientists are developing several vaccines, monoclonal antibodies, and antiviral therapies to help protect infants and young children, pregnant people (to protect their unborn babies), and older adults from severe RSV infection.
| Format | Article |
|---|---|
| Contributor | Centers for Disease Control and Prevention (CDC) |
| Source | National Center for Immunization and Respiatory Diseases (NCIRD), Division of Viral Diseases |
| Length | 1 page |
| Publication Date | 11/15/2024 |